Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEP-4199 in Bipolar I Depression (Phase 2, Japan)
jRCT2080224715Phase 2Completed
- Sponsor
- Sunovion
- Start
- Jun 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of SEP-4199 in bipolar I disorder (3 arms), sponsored by Sunovion. Started Jun 2019; status: completed.
02
Drugs
SEP-4199
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on jRCT2080224715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224715.